GSK and Pfizer have settled a lawsuit alleging Pfizer’s RSV shot Abrysvo infringed GSK’s patents. A Pfizer ...
GSK Plc and Pfizer Inc. settled a patent-infringement lawsuit over competing vaccines for RSV, ending the dispute in Delaware ...
As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory ...
Just hours after thousands of U.S. Food and Drug Administration employees were shown the door, Barclay Butler, the agency’s ...
Pfizer (PFE) and GSK (GSK) settle RSV vaccine patent lawsuit, dismissing the case with prejudice. REad more here.
GlaxoSmithKline (NYSE:GSK) and Pfizer (NYSE:PFE) have agreed to dismiss a U.S. patent lawsuit over Pfizers RSV vaccine, ...
By Blake Brittain (Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that ...
Lastly, Pfizer is a solid dividend stock. It now offers a beefy 6.8% yield, and has increased its payouts by 53.6% in the ...
However, in the later stages of the pandemic, demand for the product declined, and Moderna shifted to a loss. For example, ...
The US Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS) reported 15 more H5N1 avian flu ...
The authors assessed the patient characteristics associated with RSV vaccination among older adults hospitalized during the ...
The Immunisation Coalition will be hosting a free Flu Vaccination Day during the last week of April to counteract the record ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback